Found: 19
Select item for more details and to access through your institution.
The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐19.
- Published in:
- European Journal of Immunology, 2022, v. 52, n. 5, p. 800, doi. 10.1002/eji.202149655
- By:
- Publication type:
- Article
Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3816, doi. 10.3390/ijms21113816
- By:
- Publication type:
- Article
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection.
- Published in:
- EMBO Journal, 2022, v. 41, n. 10, p. 1, doi. 10.15252/embj.2021109622
- By:
- Publication type:
- Article
Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131934
- By:
- Publication type:
- Article
Exercise and cancer: from 'healthy' to 'therapeutic'?
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 667, doi. 10.1007/s00262-017-1985-z
- By:
- Publication type:
- Article
Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 11, p. 1177, doi. 10.1007/s00262-014-1591-2
- By:
- Publication type:
- Article
Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1.
- Published in:
- EMBO Reports, 2022, v. 23, n. 12, p. 1, doi. 10.15252/embr.202255839
- By:
- Publication type:
- Article
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.70002
- By:
- Publication type:
- Article
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06951-7
- By:
- Publication type:
- Article
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.645131
- By:
- Publication type:
- Article
The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0310915
- By:
- Publication type:
- Article
Characterization of SARS‐CoV‐2 humoral immune response in a subject with unique sampling: A case report.
- Published in:
- Immunity, Inflammation & Disease, 2023, v. 11, n. 6, p. 1, doi. 10.1002/iid3.910
- By:
- Publication type:
- Article
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.
- Published in:
- Frontiers in Psychology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.857440
- By:
- Publication type:
- Article
Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site.
- Published in:
- Cells (2073-4409), 2018, v. 7, n. 8, p. 108, doi. 10.3390/cells7080108
- By:
- Publication type:
- Article
Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor (Adv. Healthcare Mater. 1/2022).
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202270001
- By:
- Publication type:
- Article
Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor.
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202100684
- By:
- Publication type:
- Article
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20251-8
- By:
- Publication type:
- Article
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18764-3
- By:
- Publication type:
- Article